Sentíes-Madrid H, Estañol-Vidal B

Idioma: Español
Referencias bibliográficas: 36
Paginas: 15-24
Archivo PDF: 238.51 Kb.

FRAGMENTO

Definición

La cefalea tipo tensional (CTT) es de todas las cefaleas primarias la más frecuente y se caracteriza por ser opresiva, en la mayor parte de las veces de localización bilateral, con menor asociación a náusea, vómito, fonofobia o fotofobia, sin tendencia a incrementarse con la actividad física, al compararla con migraña; puede ser episódica o crónica y relacionarse o no a dolor de músculos pericraneales.

REFERENCIAS (EN ESTE ARTÍCULO)

1. International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988; 8(suppl 7):1-28. 2nd edition, Cephalalgia 24 Suppl 1 2004.

2. Rasmussen B.K., Jensen R., Schroll M., et al. Epidemiology of headache in a general population-a prevalence study. J Clin Epidemiol 1991; 44:1147-57.

3. Hagen K., Zwart J.A., Vatten L., et al. Prevalence of migraine and non-migrainous headache-head-HUNT, a large population based study. Cephalalgia 2000; 20:900-6.

4. Launer L.J., Terwindt G.M., Ferrari M.D. The prevalence of characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999; 53:537-42.

5. Lipton R.B., Stewart W.F., Diamond S., et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41:646-57.

6. Scher A.I., Stewart W.F., Lipton R.B. Migraine and headache: a meta-analytic approach. En Crombi e I.K., Croft P.R., Linton S.J., eds. Epidemiology of pain. Seattle: IASP Press, 1999:159-70.

7. Steiner T.J., Scher A.I., Stewart W.F., et al. The prevalence and disability burden of adult migraine in England and their relationships of age, gender, and ethnicity. Cephalalgia 2003; 23:519-27.

8. Breslau N., Davis G.C., Andreski P. Migraine, psychiatric disorders and suicidal attemps: and epidemiologic study of young adults. Psychiatry Res 1991; 37:11-23.

9. Pryse Phillips W., Findlay H., Tugwell P., et al. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tensiontype headache. Can J Neurol Sci 1992; 19:333-9.

10. Schwartz B.S., Stewart W.F., Simon D., et al. Epidemiology of tension-type headache. JAMA 1998; 279-381-3.

11. Lavados PM , Tenhamm E. Epidemiology of tension-type headache in Santiago, Chile: a prevalence study. Cephalalgia 1998;18:552–558.

12. Rasmussen BK, Olesen J. Epidemiology of migraine and tension-type headache. Curr Opin Neurol 1994; 7:264–271.

13. Stewart W.F., Lipton R., Celentano D.D., et al. Prevalence of migraine headache in the United States. JAMA 1992; 267:64-9.

14. Rasmussen B.K., Jensen R., Olesen J. Impact of headache on sickness absence and utilization of medi cal services. A Danish population study. J Epidemiol Community Health 1992; 46:443-6.

15. Langemark M., Olesen J. Pericranial tenderness intention headache. Cephalagia 1987; 7:249-55.

16. Langemark M., Bach F.W., Jensen T.S., et al. Decreased nociceptive flexion reflex threshold in chronic tension type headache. Arch Neurol 1993; 50:1061-4.

17. Schoenen J., Jamart B., Gerard P., et al. Exteroceptive suppression of temporali s muscle activity in chronic headache. Neurology 1987; 37:1834-6.

18. Basbaum A.I., Fields H.L. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978; 4:451- 62.

19. Langemark M., Bach F.W., Ekman R., et al. Increased cerebrospinal fluid metenkephalin immunoreactivity in patients with chronic tension type headache. Pain 1995; 63:103-7.

20. Ashina M., Lassen L.H., Bendtsen L, et al. Effect of inhibition of nitric oxide synthase on chronic tension type headache: a randomized crossovertrial. Lancet 1999a; 353:287-9.

21. Ashina M., Bendtsen L., Jensen R., et al. Possible mechanisms of faction of nitric oxide synthase inhibitors in chronica tension type headache. Brain 1999b; 122:1629-35.

22. Rolf L.H., Wiele G., Bruno G.G. 5-Hydroxitryptamine in platelets of patients with muscle contraction headache. Headache 1981; 21:10-11.

23. Kowa H., Shimomura T., Takahashi K. Platelet gamma-aminobutyric acid levels in migraine and tension type headache. Headache 1992; 32:229.32.

24. Merikangas K.R., Angst J. Migraine and psychopatology: epidemiologic and genetic aspects. Clin Neuropharm 1992; 15 (Suppl 1):275A.

25. Welch K.M. Mechanisms of chronic daily headache. Presented at 42 ND Annual Scientific Meeting of the American Headache Society, Jun 23, 2000, Montreal Quebec.

26. Cumberbatch M.J., Williamson D.J., Mason G.S., et al. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5HT1B/1D agonist. Br J Pharmacol 1999; 126:1478-86.

27. Fumal A., Schoenen J. Tension Type Headache. Rev Neurol (Paris) 2005; 161(6-7):720-2.

28. Fumal A., Schoenen J. Tension Type Headache: current research and clinical management. Lancet Neurol 2008; 7(1):70-83.

29. Mathew N.T. Tension –type headache. Curr Neurol Neurosci Rep 2006; 6(2): 100-5.

30. Cady R., Schreiber C., Farmer K., et al. Primary headaches: a convergences hypothesis. Headache 2002; 42:204- 16.

31. Lipton R.B., Stewart W.F., Cady R., et al. Sumatriptan for the range of headaches in migraine sufferers: results of the spectrum study. Headache 2000; 40:783-91.

32. Verhagen A.P., Damen L., Berger M.Y., et al. Isany one analgesic superior for episodic tension-type headache? J Fam Pract 2006; 55(2):1064-72.

33. Samton J., Mauskop A. Treatment of headaches wi th botulinum toxin. Expert Rev Neurother 2006; 6(3):313-22.

34. Ashina S., Bendtsen L., Ashina M. Curr Pain Headache Rep 2005; 9(6):415- 22.

35. Moja A.P., Cusi C., Sterzi R.R., et al. Selective serotonine re-uptake inhibitors (SSRIs) for preventing migraine and tension type headaches, Cochrane. Database Syst Rev 2005; 20(3):CD002919.

36. Silbertein S.D. Tension type headache: diagnosis and treatment. En Silberstein S.D., Lipton R.D., Goadsby P.J., Editors. Headache in Clinical Practice. Isis Medical media, 1998:101-114.